[41] reported that miR-221-3p alleviated cell apoptosis and inflammatory responses via targeting cyclin-dependent kinase inhibitor 1B (CDKN1B) in CSE-treated 16HBE cell models of chronic obstructive pulmonary disease (COPD). This evidence concerns the gene CDKN1B and chronic obstructive pulmonary disease.